Ahmedabad: Nearly 31% of Gujarat’s coastline- about 525 km, is facing erosion due to man-made activities, according to a Coastal Area Management Report by the Ministry of Jal Shakti. These findings highlight the impact of increasing emphasis on urbanisation and industrialisation at the cost of the environment. According to the report, illegal sand mining on beaches, reduced sediment supply from dams, and rising sea levels are threatening the coastline in Gujarat. This loss of land and the rise in seawater salinity can endanger agriculture, industries and coastal communities, if left unchecked. Areas of concern South Gujarat districts like Valsad, Navsari…
Author: Abizar Attari
Abizar Attari
Abizar has been writing before AI started to take over your lives! His expertise lies in analysing diverse perspectives and simplifying them for laymen. Beyond writing, storytelling and editing, he enjoys running, learning and enjoying the outdoors.
Read More
Mumbai-based pharma company Wockhardt Ltd has achieved something no other pharma company has managed to do, until now. The company has filed an application to the US Food and Drug Administration (USFDA) for its new breakthrough drug, Zaynich. Many in the medical fraternity are hailing it as a once-in-a-generation breakthrough, an antibiotic that could address a challenge doctors are increasingly facing worldwide- antibiotic resistance. A silent, stubborn challenge facing humanity Despite the rapid advances made in medical technologies, antibiotic resistance (AMR) remains a challenge that has been brewing for years, with more than 3 lakh deaths attributed to it. Widely…
Mumbai: WeWork India, the Indian arm of the New York-based managed office space company WeWork Inc., is expected to launch its highly anticipated initial public offering (IPO) on October 3. The company aims to raise Rs.3,000 crore through the issue, offloading a total of 4.6 crore shares through this pure Offer For Sale (OFS) public issue. Embassy Buildcon, the company that owns the license for WeWork in India, is looking to sell 3.54 crore shares in the issue, while the rest are being sold by an investor 1 Ariel Way Tenant. The price range for the issue is set at…
Ahmedabad: Gujarat’s groundnut farmers are getting impatient with the state government especially as unseasonal rains have impacted the groundnut crop this year. Almost 9.31 lakh farmers have registered on the e-samruddhi portal for the purchase of groundnuts at the Minimum Support Price (MSP). The deadline for the same lapsed on September 15. Still, the government hasn’t announced its procurement plans, even as farmers wait anxiously for updates, with an estimated 66 lakh metric tonnes of groundnuts on offer this year. Last year, the state bought 12 lakh tonnes of groundnuts at MSP. Farmer bodies, including the Bharatiya Kisan Sangh (BKS),…
Gurugram:India’s leading food delivery platform Zomato is now aiming to differentiate itself by advocating for healthy takeout choices- through a ‘Healthy Mode’ AI-powered feature that ranks restaurant dishes using AI and the dish’s ingredients. Currently live in Gurugram, the company is expected to roll out this feature nationally in the coming days. This move comes at a time when ordering from Zomato has become a convenient solution for those who don’t want to make the effort of cooking their own meals- which are mostly cheaper and more nutritious than restaurant-ordered ones. Rising urbanization, poor work-life balance and a lack of…
India is witnessing a demographic shift like no other. On one hand, we have underdeveloped states like Bihar, Jharkhand and Eastern UP where the birth rate remains stubbornly high with more than 2.3 births per woman, while most of India has seen its fertility rates drop below the population replacement rate of 2.1 children per woman. This essentially means that the working age population has been reducing steadily, with the number of senior citizens- those aged 60 and above- are now set to increase from 10.5% of the population in 2023 to 20.8% by 2030. A similar trend is already…
Mumbai: Pharma major Lupin has announced its entry into the ophthalmology market with the acquisition of Netherlands-based VISUfarma for €190 million (about Rs.1970 crores). This move is expected to help Lupin expand its therapeutic portfolio beyond chronic diseases like TB and Diabetes into Opthamology while also helping it expand into Europe. Lupin’s wholly owned Europe subsidiary, Nanomi B.V., has signed a defininative agreement to acquire VISUfarma, the company said in a press release to the bourses. Headquartered in Amsterdam, VISUfarma specialises in eye care products, marketing a range of products to treat dry eyes, glaucoma, retinal health and eyelid hygiene.…
New Delhi: The Adani Group seems to be unstoppable. Gautam Adani’s insatiable appetite for expansion has seen him spend like there’s no tomorrow for expensive acquisitions in cement, power plants, aerospace and now, the real estate assets of the beleaguered Sahara Group. After taking over the reins of the Dharavi redevelopment plan, the Adani Group is now all set to take over more than 88 properties owned by the Sahara Group, including the 8,800-acre Aamby Valley City in Maharashtra, Hotel Sahara Star in Mumbai, the 170-acre Sahara Shahar in Lucknow, among others, scattered across various states. According to various media…
Nashik: Chairman and Managing Director of Cupid Limited, Mr Aditya Kumar Halwasiya, looks all set for an ambitious roadmap for the reproductive wellness company, as it reported its best quarter results so far. The company reported a net profit of Rs.40.89 crore in Q2FY26, on the back of strong institutional orders and new product launches in its FMCG vertical. The company reported a total income of Rs.203.18 crore in the quarter, with its net worth crossing Rs.342 crores. Currently, the company is looking forward to the commissioning of its Palava plant in the coming months, along with its expansion across…
Vadodara: US President Donald Trump’s latest announcement of a 100% tariff on branded pharmaceuticals has left Gujarat’s Rs.10,000 crore pharma industry jittery, even though the tariff usually doesn’t apply to them. India exports nearly 30% of its pharmaceuticals to the US, but most of them are life saving generic medicines- copies of branded drugs that offer the same efficacy at a fraction of the cost of branded drugs. Donald Trump’s post on Truth Social has said the tariff is for ‘branded or patented’ pharmaceutical products, which does not include generics, but there is still no clarity on this announcement, as…
